A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention. / Sathananthan, Janarthanan; Fraser, Rob; Hatoum, Hoda; Barlow, Aaron M.; Stanová, Viktória; Allen, Keith B.; Chhatriwalla, Adnan K.; Rieu, Régis; Pibarot, Phillippe; Dasi, Lakshmi Prasad; Søndergaard, Lars; Wood, David A.; Webb, John.
I: EuroIntervention, Bind 14, Nr. 16, 2020, s. 1409-1416.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention
AU - Sathananthan, Janarthanan
AU - Fraser, Rob
AU - Hatoum, Hoda
AU - Barlow, Aaron M.
AU - Stanová, Viktória
AU - Allen, Keith B.
AU - Chhatriwalla, Adnan K.
AU - Rieu, Régis
AU - Pibarot, Phillippe
AU - Dasi, Lakshmi Prasad
AU - Søndergaard, Lars
AU - Wood, David A.
AU - Webb, John
PY - 2020
Y1 - 2020
N2 - Aims: Bioprosthetic valve fracture (BVF) may improve transvalvular gradients and transcatheter heart valve (THV) expansion during VIV interventions. However, the optimal timing of BVF is unknown. We assessed the impact of timing of BVF (before versus after) for valve-in-valve (VIV) intervention, on hydrodynamic function and THV expansion. Methods and results: Three THV designs were assessed, a 23 mm SAPIEN 3 (S3), small ACURATE neo (ACn) and 23 mm Evolut R, deployed into 21 mm Mitroflow bioprosthetic surgical valves. We evaluated each THV in three groups: 1) no BVF, 2) BVF before VIV, and 3) BVF after VIV. Hydrodynamic testing was performed using a pulse duplicator to ISO 5840:2013 standard. Transvalvular gradients were lower when BVF was performed after VIV for the S3 (no BVF 15.5 mmHg, BVF before VIV 8.0 mmHg, BVF after VIV 5.6 mmHg), and the ACn (no BVF 9.8 mmHg, BVF before VIV 8.4 mmHg, BVF after VIV 5.1 mmHg). Transvalvular gradients were similar for the Evolut R, irrespective of performance of BVF or timing of BVF. BVF performed after VIV resulted in better expansion in all three THV designs. The ACn and Evolut R samples all had a mild degree of pinwheeling, and BVF timing did not impact on pinwheeling severity. The S3 samples had severe pinwheeling with no BVF, and significant improvement in pinwheeling when BVF was performed after VIV. Conclusions: BVF performed after VIV was associated with superior THV expansion in all three THV designs tested, with lower residual transvalvular gradients in the S3 and ACn THVs. The Evolut R had similar hydrodynamic performance irrespective of BVF timing. Timing of BVF has potential implications on THV function.
AB - Aims: Bioprosthetic valve fracture (BVF) may improve transvalvular gradients and transcatheter heart valve (THV) expansion during VIV interventions. However, the optimal timing of BVF is unknown. We assessed the impact of timing of BVF (before versus after) for valve-in-valve (VIV) intervention, on hydrodynamic function and THV expansion. Methods and results: Three THV designs were assessed, a 23 mm SAPIEN 3 (S3), small ACURATE neo (ACn) and 23 mm Evolut R, deployed into 21 mm Mitroflow bioprosthetic surgical valves. We evaluated each THV in three groups: 1) no BVF, 2) BVF before VIV, and 3) BVF after VIV. Hydrodynamic testing was performed using a pulse duplicator to ISO 5840:2013 standard. Transvalvular gradients were lower when BVF was performed after VIV for the S3 (no BVF 15.5 mmHg, BVF before VIV 8.0 mmHg, BVF after VIV 5.6 mmHg), and the ACn (no BVF 9.8 mmHg, BVF before VIV 8.4 mmHg, BVF after VIV 5.1 mmHg). Transvalvular gradients were similar for the Evolut R, irrespective of performance of BVF or timing of BVF. BVF performed after VIV resulted in better expansion in all three THV designs. The ACn and Evolut R samples all had a mild degree of pinwheeling, and BVF timing did not impact on pinwheeling severity. The S3 samples had severe pinwheeling with no BVF, and significant improvement in pinwheeling when BVF was performed after VIV. Conclusions: BVF performed after VIV was associated with superior THV expansion in all three THV designs tested, with lower residual transvalvular gradients in the S3 and ACn THVs. The Evolut R had similar hydrodynamic performance irrespective of BVF timing. Timing of BVF has potential implications on THV function.
KW - Aortic stenosis
KW - Balloon valvuloplasty
KW - Valve restenosis
KW - Valve-in-valve
U2 - 10.4244/EIJ-D-19-00939
DO - 10.4244/EIJ-D-19-00939
M3 - Journal article
C2 - 31854302
AN - SCOPUS:85083374672
VL - 14
SP - 1409
EP - 1416
JO - EuroIntervention
JF - EuroIntervention
SN - 1774-024X
IS - 16
ER -
ID: 250168332